SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001376474-24-000295
Filing Date
2024-07-10
Accepted
2024-07-10 16:40:21
Documents
14
Period of Report
2024-07-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 10X CAPITAL VENTURE ACQUISITION CORP. III - FORM 8-K SEC FILING vcxb-20240710.htm   iXBRL 8-K 23516
  Complete submission text file 0001376474-24-000295.txt   180718

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcxb-20240710_def.xml EX-101.DEF 14107
3 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vcxb-20240710_lab.xml EX-101.LAB 20406
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcxb-20240710_pre.xml EX-101.PRE 13262
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcxb-20240710.xsd EX-101.SCH 2755
16 EXTRACTED XBRL INSTANCE DOCUMENT vcxb-20240710_htm.xml XML 4994
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 241110352
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)